Show simple item record

dc.contributor.authorSoo, R
dc.contributor.authorStone, E
dc.contributor.authorCummings, K
dc.contributor.authorJett, J
dc.contributor.authorField, J
dc.contributor.authorGroen, H
dc.contributor.authorMulshine, J
dc.contributor.authorYatabe, Y
dc.contributor.authorBubendorf, L
dc.contributor.authorDacic, S
dc.contributor.authorRami-Porta, R
dc.contributor.authorDetterbeck, F
dc.contributor.authorLim, E
dc.contributor.authorAsamura, H
dc.contributor.authorDonington, J
dc.contributor.authorWakelee, H
dc.contributor.authorWu, Y
dc.contributor.authorHiggins, K
dc.contributor.authorSenan, S
dc.contributor.authorSolomon, B
dc.contributor.authorKim, D
dc.contributor.authorJohnson, M
dc.contributor.authorYang, J
dc.contributor.authorSequist, L
dc.contributor.authorShaw, A
dc.contributor.authorAhn, M
dc.contributor.authorCosta, D
dc.contributor.authorPatel, J
dc.contributor.authorHorn, L
dc.contributor.authorGettinger, S
dc.contributor.authorPeters, S
dc.contributor.authorWynes, M
dc.contributor.authorFaivre-Finn, Corinne
dc.contributor.authorRudin, C
dc.contributor.authorTsao, A
dc.contributor.authorBaas, P
dc.contributor.authorKelly, R
dc.contributor.authorLeighl, N
dc.contributor.authorScagliotti, G
dc.contributor.authorGandara, D
dc.contributor.authorHirsch, F
dc.contributor.authorSpigel, D
dc.date.accessioned2017-07-13T10:50:02Z
dc.date.available2017-07-13T10:50:02Z
dc.date.issued2017-05-27
dc.identifier.citationScientific advances in thoracic oncology 2016. 2017 J Thorac Oncolen
dc.identifier.issn1556-1380
dc.identifier.pmid28579481
dc.identifier.doi10.1016/j.jtho.2017.05.019
dc.identifier.urihttp://hdl.handle.net/10541/620445
dc.description.abstractLung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The IASLC and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for non-small cell lung cancer, small cell lung cancer, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.
dc.language.isoenen
dc.rightsArchived with thanks to Journal of thoracic oncology : official publication of the International Association for the Study of Lung Canceren
dc.titleScientific advances in thoracic oncology 2016.en
dc.typeArticleen
dc.contributor.departmentCancer Science Institute of Singapore, National University of Singapore, Singapore, Singaporeen
dc.identifier.journalJournal of Thoracic Oncologyen
refterms.dateFOA2018-07-13T00:00:00Z
html.description.abstractLung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The IASLC and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for non-small cell lung cancer, small cell lung cancer, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.


Files in this item

Thumbnail
Name:
PIIS1556086417304276.pdf
Size:
1.903Mb
Format:
PDF
Description:
Accepted author manuscript

This item appears in the following Collection(s)

Show simple item record